此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

 

        辉瑞积极向中国引进创新药品、提供医疗卫生专业培训、在自然灾害中积极响应灾区人民对医疗健康的需求、支持社区健康工作,积极推动健康事业的发展与改革……这些都充分展示了我们对中国健康事业的承诺。保护环境是促进健康生活的一个重要内容,辉瑞积极通过降低碳排放、控制资源消耗以最大程度地减少对环境的影响。
        辉瑞积极倡导履行企业社会公民义务并身体力行,认真承担对我们的利益相关方及对我们工作和生活所在的社区的社会责任

        Pfizer has demonstrated a commitment to improving health in China by introducing over 50 innovative drugs, conducting educational healthcare programs, responding to healthcare needs during and after natural disasters, supporting community health initiatives and actively promoting healthcare development and reform. Part of promoting a healthy life is protecting the environment in which we live, that is why we also actively work to reduce our impact on the planet, reducing carbon emissions and consumption of resources.
        Pfizer always advocates performing the obligation of the corporate citizen, and assumes the social responsibilities for our stakeholders and the community where we work and live through various CSR programs.

我们致力于提高药物的可及性
  • 我们与中国癌症基金会和Axios基金会进行合作,通过“索坦患者支持项目”(SPAP)提高低收入患者使用索坦的机会,并提高对两种治疗难度较高癌症——转移性肾细胞癌(mRCC和胃肠道间质瘤(GIST)的治疗水平。

  • 我们关注社区慢性病预防和控制项目
  • 2006年和2007年,辉瑞与浙江省疾病预防控制中心合作建立了一个疾病管理团队,还与上海市疾病预防控制中心合作进行疾病管理项目。这两个项目旨在为高血压患者提供免费的健康管理和疾病管理,使广大的社区居民获益。
  • 2008年,辉瑞与卫生部心血管病防治研究中心合作,启动了社区慢性病防控项目,打造社区慢病防治专业队伍。
  • 2010年,我们与北京市卫生局合作,启动“健康北京人-母婴健康行动”项目。我们与广大医疗工作者密切协作,利用辉瑞在母婴健康领域的丰富经验为我们生活和工作的社区做出贡献。
  • 我们致力于增强社区卫生中心医疗能力,帮助超过15,000名患者管理慢性病和降低血压。辉瑞“疾病管理项目”(DMaP)被证明是一种高性价比、可复制的具有科学性的慢性病管理模式。

  • 辉瑞“全球健康合作伙伴”计划
  • 我们通过辉瑞“全球健康合作伙伴”计划在中国成功实施了戒烟项目,为中国政府决定2011年在所有医院实现无烟医院提供了一种可借鉴的模式

  • 我们致力于慈善事业
  • 过去十年,我们向为偏远地区和贫困地区提供免费白内障治疗手术的“中华健康快车基金会”捐赠了超过645万人民币。

  • 打击伪劣药物保护患者安全
  • 我们与执法和监管部门建立了紧密的合作关系,查处并打击假冒辉瑞产品的不法生产商和销售商,保障消费者的用药安全。
  • 我们在多个项目上与中国食品药品管理局(SFDA)紧密合作,组织培训和采取法律行动,整治网上药店的掺假药品及伪劣药品。
  • 我们苏州营养品厂的建设获得了苏州工业园区颁发的环境保护项目“绿色建筑”奖。

  • 我们关注环境保护
  • 我们积极努力降低温室气体排放和水消耗量的增幅,并将废弃物的产生降低了9.2%。
  • 我们在大连药厂建设了8个节能项目,年能耗降低8%,节省5,084度电能,降低二氧化碳排放2,835吨。
  • 我们完成了苏州营养品新厂的建设,获得苏州工业园颁发的环境保护项目“绿色建筑”奖。

    关注我们的工作环境
  • 我们持续地对新的供应商进行环境、健康和安全(EHS)评估并定期对主要供应商进行考核,以保证采购决定严格符合“药品供应链行动”(由制药企业为帮助供应商改善在EHS和用工方面的表现而成立的组织)的要求。

  • 企业社会责任得到广泛认可
  • 中国红十字会于2008和2009年分别授予辉瑞“特殊贡献奖”以表彰我们在地震灾害中的人道主义行动,辉瑞是制药行业中唯一一家获奖的跨国公司。2010年,辉瑞为青海玉树地震震区捐助了价值500万元人民币的现金和药品。
  • 辉瑞中国在“公益时报”公布的“2009年公司慈善榜”年度排名中名列第21位。在该榜单所评估的850多家本地和国际企业中,辉瑞是唯一进入前50位的制药公司。
  • 辉瑞在2009年有2,000家跨国公司和本地公司参与的评选中获得“中国杰出慈善贡献机构10强”的称号。辉瑞是唯一一家获奖的跨国公司。

  • Access to Medicines
  • We increased access to Sutent for low-income patients and increased healthcare capacity for two difficult-to-treat cancers through the Sutent Patient Assistance Program (SPAP) in partnership with the Cancer Foundation of China and the Axios Foundation.

  • Community Programs
  • In 2006 and 2007, we collaborated with the Zhejiang Center for Disease Control and Prevention to form a disease management team. Pfizer later collaborated with the Shanghai Center for Disease Control and Prevention to carry out disease management programs.
  • In 2008, we collaborated with the Cardiovascular Disease Control Center of the Ministry of Health to launch a community chronic disease prevention and control project.
  • In 2010, We cooperated with Beijing Health Bureau to launch “Be a Healthier Beijing Citizen – Mother and Infant Health Action” Campaign, a joint collaboration between Pfizer's Vaccines and Nutritionals business
  • We increased capacity in community health centers and helped over 15,000 patients manage chronic disease and lower blood pressure. Pfizer's Disease Management Program (DMaP) has demonstrated a scientific, cost-effective and replicable model for chronic disease management.

  • Global Health Programs
  • We conducted a successful smoking cessation program through Pfizer's Global Health Partnerships, supplying the model for the Chinese Government's decision to make all hospitals in China smoke-free by 2011.

  • Grants and Contributions
  • o We donated over RMB 6.45 million in the last decade to the Chinese Foundation for Lifeline Express, an organization that provides free cataract operations in remote and poverty-stricken areas of China.

  • Partnering with Regulatory Agencies and Health Care Professionals
  • We established strong partnerships with enforcement and regulatory agencies in an effort to detect and disrupt major manufacturers and distributors of counterfeit Pfizer products.
  • We worked closely with the State Food and Drug Administration (SFDA) on many projects to address tampered medicine, counterfeits from online pharmacies.

  • Protecting the Environment
  • We slowed the growth of our greenhouse gas emissions and water consumption and decreased our waste by 9.2 percent.
  • We reduced annual energy consumption by 8 percent at our Dalian plant through eight energy-saving projects, saving 5,084 megawatt hours and reducing carbon dioxide emissions by 2,835 tons.
  • We completed the construction of a new infant nutritional products facility in Suzhou, for which Suzhou Industrial Park awarded a “Green Building” prize.

  • Workplace Responsibility
  • We continuously conduct environmental, health and safety (EHS) assessments of new suppliers and regularly assess our key suppliers to ensure that sourcing decisions comply with the Pharmaceutical Supply Chain Initiative, a group of pharmaceutical companies who share the goal of helping suppliers achieve better EHS and labor performance.

  • Widely Recognized CSR Contributions
  • The Red Cross Society of China honored Pfizer with a “Special Contribution Award” for its humanitarian response to the Wenchuan earthquake in Sichuan Province in 2009, making Pfizer the only multinational company in the pharmaceutical industry to receive this award. In 2010, Pfizer also donated RMB 5 million for the relief work of earthquake which struck Yushu County, Qinghai Province.
  • Pfizer China was ranked No. 21 on the “2009 Corporation Charity Chart”, an annual list published by the Philanthropy Times. Out of the more than 850 domestic and international businesses evaluated on the list, Pfizer was the only pharmaceutical company in the Top 50.
  • We were ranked among the “Top 10 China Philanthropy Outstanding Contribution Organizations” out of 2,000 multinational and domestic corporations in 2009. Pfizer is the only MNC to have won this award.

  • 未经51job.com同意,不得转载本网站之所有招聘信息及作品;无忧工作网版权所有©1999-2020